Physician profile
Dawn Young
NPI 1295395150
$1,610.09
in general payments reported to CMS, 2019-2025
18 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $486 · 2022: $329 · 2023: $216 · 2024: $217 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $263.78 | 2022-2025 | |
| Alkermes, INC. | $243.95 | 2025 | Lybalvi, Aristada, Vivitrol |
| Esperion Therapeutics, INC. | $180.79 | 2021-2023 | Nexletol |
| Amgen INC. | $119.48 | 2021-2023 | Repatha |
| Melinta Therapeutics, LLC | $119.02 | 2024 | Rezzayo |
| Merck Sharp & Dohme LLC | $102.18 | 2022-2023 | Verquvo |
| Abbvie INC. | $98.71 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $83.38 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $81.41 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $69.23 | 2021-2025 | Cobenfy, Camzyos |
| Kowa Pharmaceuticals America, INC. | $62.81 | 2021-2023 | Livalo |
| Boston Scientific Corporation | $40.19 | 2021 | |
| Amarin Pharma, INC. | $38.65 | 2021-2022 | |
| Atricure, INC. | $32.89 | 2022 | |
| Novo Nordisk INC | $20.19 | 2023 | Ozempic |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.91 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $18.58 | 2025 | Abilify Asimtufii |
| Pfizer INC. | $15.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.